Abstract:Objective To evaluate the efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis.Methods This is a multieenter,randomized,doubleblind,and positive drug parallel controlled clinical trial.The patients with allergic rhinitis and who met the eligibility criteria were enrolled and divided into the test group and the control group.The patients in the test group received beclometasone dipropionate aqueous nasal spray and the patients in the control group received beclometasone dipropionate nasal spray.All patients in the 2 groups were administered two inhalations of beclomethasone dipropionate into each nostril twice daily(each inhalation contains beclometasone dipropionate 50 μg) for 14 days.The efficacy of these two drugs was evaluated according to the total scores of symptoms of rhinitis,scores of signs and quality of life and percentage changes of patients in three scores mentioned above when the treatment was over.The safety of these two drugs was evaluated according to the incidence of adverse events/adverse reactions,the results of laboratory tests,and ECG when the treatment was over.Results A total of 239 patients were included into the efficacy analysis.Of them,120 patients were in the test group and 119 were in the control group.There was no significant differences in gender, age,rhinitis symptoms,and signs before the drug administration between the 2 groups(P>0.05).The total scores of symptoms of rhinitis,scores of signs and quality of life on days 7 and 14 of treatment decreased significantly as compared with those obtained before the treatment in the both groups(P<0.05), but there was no significant difference in the extent of decrease between the 2 groups(P>0.05).When the treatments were over,the differences in the percentage changes of patients of rhinitis symptoms,signs and quality of life scores before and after treatments in the both 2 groups were statistically significant(P< 0.05),but there was no significant difference between the 2 groups(P>0.05).A total of 241 patients were included into the safety analysis.Of them,121 patients were in the test group and 120 were in the control group.There were 12 adverse events in 10 patients in the test group.Of them,2 events in the 2 patients were adverse drug reactions,including 1 case with throat discomfort and another case with nose bleeding.There were 20 adverse events in the 13 patients in the control group.Of them,11 events in 7 patients were adverse drug reactions and nose bleeding and dry nose were their major manifestations.There was no significant difference in the incidence of adverse events between the 2 groups(P>0.05).No severe adverse events occurred during the clinical trial.Conclusion Beclometasone dipropionate aqueous nasal spray could effectively control the symptoms of allergic rhinitis and its efficacy and safety were similar to those of beclometasone dipropionate nasal spray.

Azelastine nasal spray in treating perennial allergic rhinitis: a randomly double-blind trial

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% Versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-severe Allergic Rhinitis.

Randomized Controlled Clinical Trial on Azelastine Hydrochloride Tablet Versus Loratadine in the Treatment of Allergic Rhinitis

Double-blind, placebo-controlled trial of the efficacy and safety of azelastine hydrochloride in children with perennial allergic rhinitis

Efficacy and Safety of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis: a Randomized Controlled Trial

Onset-of-Efficacy of Azelastine HCl 0.15% Nasal Spray for allergic rhinitis in an environmental exposure chamber

Efficacy and Safety of Mizolastine in the Treatment of Perennial Allergic Rhinitis

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis

Efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis:a multicenter,randomized,double-blind,and controlled trial

Clinical Randomized Controlled Trials of Levocetirizine in Treatment of 72 Patients with Anaphylactic Rhinitis

Acupuncture for Moderate to Severe Allergic Rhinitis: A Non-Randomized Controlled Trial.

Analysis of the efficacy of azelastine nasal spray combined with mussel mucin in the treatment of allergic rhinitis and the influence of peripheral blood CCL26 and CCR3 levels.

A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial

A Study on the Efficacy and Safety of Azelastine in the Treatment of Urticaria

Efficacy of Acupuncture on Moderate and Severe Allergic Rhinitis

Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis

Randomized Controlled Clinical Trial Comparing Budesonide Plus Montelukast and Loratadine Plus Montelukast for Treatment of Moderate and Severe Persistent Allergic Rhinitis

Study on Therapeutic Effect of Complex Prescription Cromolyn Sodium Nasal Spray in the Treatment of Allergic Rhinitis

Clinical study of the combination therapy with intranasal antihistamine and nasal corticosteroids in the treatment of nasal obstruction of persistent non-allergic rhinitis

Efficacy of Loratadine Combined with Budesonide Nasal Spray in the Treatment of Allergic Rhinitis and its Effect on Th1/Th2 Cytokines

Efficacy and safety of pemirolast potassium in comparison with tranilast for bronchial asthma and allergic rhinitis:a multicenter,randomized,double-blind,double-dummy,parallel-group trial